Last update 26 Dec 2024

Lumrotatug

Overview

Basic Info

Drug Type
Monoclonal antibody
Synonyms
CM 313, CM-313, CM313
Target
Mechanism
CD38 inhibitors(Lymphocyte differentiation antigen CD38 inhibitors)
Inactive Indication-
Inactive Organization-
Drug Highest PhasePhase 2
First Approval Date-
Regulation-
Login to view timeline

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Purpura, Thrombocytopenic, IdiopathicPhase 2
CN
01 Nov 2024
Refractory Multiple MyelomaPhase 2-28 Feb 2024
Multiple MyelomaPhase 2
CN
17 Jan 2024
Systemic Lupus ErythematosusPhase 2
CN
14 Oct 2022
Relapse multiple myelomaPhase 1
CN
15 Apr 2021
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 1/2
22
cbwdlrbnsn(irdujdagpi) = The most common that occurred during the study were infusion-related reaction (in 32% of the patients) and upper respiratory tract infection (in 32%). rzqjhocppl (wzcmfyccfy )
Positive
19 Jun 2024
Phase 2
21
djvhpvqtcq(eejjsmntbf) = 6 (6/21, 28.6%) had an infusion-related reaction (IRR) at the first dose but none at subsequent doses. The severity of IRR was grade 1 or 2 (according to CTCAE version 5.0) cjtyjzldbu (greuvyjxus )
Positive
09 Dec 2023
Phase 1
34
hpykqtlayx(bcwqlwaitd) = Grade 3 or higher treatment-emergent adverse events (TEAEs) were reported in 15/34 (44.1%) pts (8 [23.5%] were considered drug related); there were no grade 5 TEAEs owauyclfsq (vllifxgqkr )
-
08 Jun 2023
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free